Being classified as a Schedule 3 drug under the U.S. Controlled Substances Act means the substance has a moderate to low potential for physical and psychological dependence, lower abuse risk than Schedules 1 or 2, but higher than Schedule 4, while possessing accepted medical uses in treatment.

Core Criteria

These drugs meet specific DEA standards: lower abuse potential than Schedules I/II, current medical acceptance in the U.S., and risk of moderate/low physical dependence or high psychological dependence.

This classification balances therapeutic value against misuse risks, guiding prescriptions and enforcement.

Common Examples

  • Ketamine : Used for anesthesia and depression treatment.
  • Anabolic steroids like testosterone: Prescribed for hormone deficiencies.
  • Codeine combinations (e.g., Tylenol with Codeine <90mg): For moderate pain.

Prescription Rules

Schedule 3 drugs require a standard prescription (no special DEA form like Schedule 2), with refills allowed up to five times in six months under a doctor's order.

Pharmacies track them strictly to prevent diversion.

Risks and Context

Abuse Potential : Moderate; misuse can lead to tolerance, withdrawal, or addiction, though less severe than higher schedules.

Recent discussions (as of 2025) highlight ongoing reviews, like cannabis proposals for Schedule 3 reclassification, sparking debates on medical access vs. federal control.

TL;DR : Safer profile for medical use but still regulated to curb non- medical abuse.

Information gathered from public forums or data available on the internet and portrayed here.